Real-World Registry Study on Patient Satisfaction With TransLoc 3D SI Joint Fusion
NCT ID: NCT06487936
Last Updated: 2024-08-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
120 participants
OBSERVATIONAL
2024-08-15
2024-12-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Post-Market Clinical Study on a Modular SI Joint Fusion System
NCT05916092
iFuse TORQ for the Treatment of Sacroiliac Joint Dysfunction
NCT05870488
Sacroiliac (SI) Joint Transfixing and Fusion: Meaningful Long Term Outcomes With Nevro1
NCT06909292
Clinical Outcome and Fusion Results Using the SiJoin® Transfixing Sacroiliac Fusion Device
NCT05712850
SI Joint Stabilization in Long Fusion to the Pelvis
NCT04062630
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Implanted TransLoc 3D SIJ Fusion Patients
Patients who were diagnosed with sacroiliitis and were treated with the TransLoc 3D System ≥ 1 year ≤ 18 months at the time of consent.
TransLoc 3D SI Joint Fusion System
Satisfaction survey will be administered to collect real world evidence on patients that previously received the TransLoc 3D System commercially.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
TransLoc 3D SI Joint Fusion System
Satisfaction survey will be administered to collect real world evidence on patients that previously received the TransLoc 3D System commercially.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Confirmed Implant of the Transloc 3D Fusion System
* Did not have Transloc device removed or another manufacturer device implanted post Transloc
* Does not have other manufacturer's titanium or metal implant
* Patient may be included with prior allograft implant
* Willing to participate and give written consent
* Must have or planned CT post ≥1 year per standard of care
Exclusion Criteria
* Patient is unable to sign the Informed Consent
* Implant of other manufacturer's titanium or alternative metal implant
* Revision with another manufacturer's implant
* Fracture or unresolved trauma of implant side after implantation of TransLoc
* Patient unwilling to participate in Patient Satisfaction Survey
* Patient has not returned for Standard of Care follow-up
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
CornerLoc
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lee James, DO
Role: PRINCIPAL_INVESTIGATOR
Advanced Orthopedic Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Advanced Orthopedic Center
Port Charlotte, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Lee James, DO
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RELIEF-02-24
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.